Artificial intelligence predicts pregnancy complications based on cytokine profiles
Fawaz Azizieh1, Bulent Yilmaz2, Raj Raghupathy3
1College of Integrative Studies, Abdullah Al Salem University, Khaldiya, Kuwait.
Summary
Predicting pregnancy complications early is crucial. This study uses AI and cytokine analysis to accurately forecast conditions like preterm delivery and hypertension, aiding timely intervention.
Area of Science:
- Reproductive immunology
- Computational biology
- Biomedical data science
Background:
- Early prediction of pregnancy complications is vital for effective prevention and management.
- Maternal and fetal health outcomes are significantly impacted by timely interventions.
- Understanding predictive biomarkers can reduce pregnancy-related pathogenesis.
Purpose of the Study:
- To investigate the prognostic value of cytokines as predictors of pregnancy complications.
- To apply unbiased artificial intelligence/machine learning (AI/ML) methods for predictive modeling.
- To differentiate between normal delivery and various pregnancy complications using cytokine profiles.
Main Methods:
- Analysis of seven cytokines from activated peripheral blood mononuclear cells (PBMC) in 127 women with complications and 97 controls.
- Application of AI/ML algorithms including kNN, SVM, decision tree, and ensemble classification.
- Binary classification tasks to predict conditions like recurrent spontaneous miscarriage (RSM), preterm delivery (PTD), pregnancy-induced hypertension (PIH), and premature rupture of fetal membranes (PROM).
Main Results:
- Significant differences in IL-2 and IFN-γ cytokine levels were observed across various pregnancy conditions.
- High accuracies and f-measures were achieved using Ensemble (Bagged), QDA, and SVM (Cubic) classifiers.
- AI/ML models effectively distinguished normal delivery from pregnancy complications.
Conclusions:
- A novel AI/ML-based methodology for predicting pregnancy complications using cytokine levels has been developed.
- Cytokine profiles from peripheral blood cells serve as valuable biomarkers for early detection.
- This approach supports timely clinical interventions to improve maternal and fetal outcomes.


